A UK and US based digital insights consultancy has launched a new platform, DOL Finder, that enables users to identify the most influential healthcare professionals discussing major diseases, treatments and trials on social media across the globe.
The new database, developed by Creation Healthcare, was unveiled this week at the European Association for the Study of Diabetes (EASD) Conference in Madrid, and hopes to support pharmaceutical organisations in optimising their HCP engagement and marketing delivery.
Among the platforms features is a tool enabling users to identify ‘Digital Opinion Leaders’ – those healthcare professionals who have the largest impact in online discussions regarding particular diseases and treatments. DOL Finder also includes filtering mechanisms by which users can narrow their search to certain specialties, countries, and date ranges.
The most influential healthcare professionals are ranked through a consideration of analytics including social media activity, peer-to-peer trust and engagement, and audience reach. In the type 2 diabetes space, in which the platform first launches, Creation Healthcare say that their dataset will draw on the online activity of more than 30,000 healthcare professionals.
The platform will also offer users an opportunity to learn about individual and collective HCP views on, and sentiments towards, several subject areas including manufacturers, products, treatments and trial results.
DOL Finder launches first in the type 2 diabetes space, though Creation Healthcare anticipate that the platform’s capabilities will extend to any disease indication in the coming months.
The consultancy is able to analyse the social media conversations of healthcare professionals using CREATION Pinpoint®, the world’s only AI-powered global database of more than 3 million healthcare professionals’ social media profiles, analysing the collective intelligence of almost 2 billion social media posts by those on the front lines of healthcare.
This week’s launch “fulfils a long-held ambition” to make social media data more accessible to the pharmaceutical industry, a company press release said.
Daniel Ghinn, Creation Healthcare’s Founder and CEO, said that the new platform “opens up access to Creation’s deep HCP social media intelligence platform, built over the past twelve years. For the first time, you can explore the data and identify the most impactful HCP Digital Opinion Leaders tailored to your needs and objectives.”
“We’ve always been asked when we would make our data directly available to clients, and it’s been a dream to get them closer to our insights,” Ghinn continued. “It’s now time to open up the depth of our analytical capacities to a wider pharmaceutical audience.”
